top
第429期
(2021/03/25出刊)
歐盟掛保證 多國恢復打AZ疫苗

 Many European countries have suspended the use of AstraZeneca’s COVID-19 vaccine following reports of blood clots. However, Germany, France and several other EU countries on March 18th decided to continue using the AstraZeneca vaccine after the European Medicines Agency (EMA) shored up confidence in the shot.
 Following an investigation into 30 cases of unusual blood disorders, the EMA concluded that the vaccine’s benefits in protecting people from coronavirus outweighs the possible risks, though a link between blood clots and the shot could not be definitively ruled out.
 Germany resumed administering the AstraZeneca vaccine from March 19th. German Health Minister Jens Spahn said suspending the vaccine out of caution had been the right call. French Prime Minister Jean Castex received the shot himself on March 19th. It is up to individual EU states to decide whether and when to re-start vaccinations using the AstraZeneca vaccine.

 在陸續傳出接種阿斯特捷利康新冠疫苗(簡稱AZ疫苗)而產生血栓的案例後,許多歐洲國家一度暫停施打這款疫苗。但三月十八日歐盟藥品管理局為AZ疫苗的安全掛保證後,德國、法國等歐盟國家決定恢復施打。
 歐盟藥品管理局針對三十起罕見的血液失調病例進行調查後指出,雖然無法完全排除AZ疫苗與血栓之間的關聯性,但AZ 疫苗能安全有效的幫助民眾免於感染新冠肺炎,利多於弊。
 德國從三月十九日開始恢復施打AZ疫苗。德國衛生部長斯帕恩說,之前出於謹慎而暫停使用疫苗是正確的決定。法國總理卡斯泰也在三月十九日帶頭接種AZ疫苗。歐盟各國可以自行決定是否恢復使用AZ疫苗,以及何時開始施打。